MariMed (OTCMKTS:MRMD) Posts Quarterly Earnings Results

MariMed (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%.

MariMed Price Performance

MRMD opened at $0.12 on Thursday. MariMed has a 12-month low of $0.11 and a 12-month high of $0.34. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. The firm has a market capitalization of $43.87 million, a P/E ratio of -2.88 and a beta of 2.69. The stock has a fifty day moving average of $0.12 and a 200-day moving average of $0.15.

MariMed Company Profile

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.